Improve motor function using StimSearch
- Trial ID
- NCT06205043
- Official Title
- Enhancing Deep Brain Stimulation Programming for Parkinson's Disease: A Semi- Automatic Algorithm-Guided Approach Using StimSearch- A Double Blind Randomized Study
- Goal
- Improve motor function using StimSearch
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- Jaslok Hospital and Research Centre
- Study Type
- INTERVENTIONAL
- Enrollment
- 30 participants
- Conditions
- Parkinson Disease
- Interventions
- StimSearch programming algorithm software, Clinician based programming
Plain-Language Summary
The goal is to make deep brain stimulation programming more efficient and effective, so people with Parkinson's get better symptom control sooner and with fewer visits. The approach uses StimSearch, a semi-automatic algorithm-guided software that analyzes patient assessments and proposes DBS parameter settings, and the study will compare those algorithm suggestions to usual clinician-based programming in a double-blind, randomized way. They are looking for people with confirmed bilateral idiopathic Parkinson's who have significant motor symptoms off medication (UPDRS III ≥ 25), who improved by at least 30% on a pre-operative levodopa challenge, who can give informed consent, and who do not have major psychiatric conditions like substantial depression.
Locations
- Jaslok Hospital And Research Centre, Mumbai, Maharashtra, India
Frequently Asked Questions
- What is this trial testing?
- This trial is studying StimSearch programming algorithm software. The goal is to make deep brain stimulation programming more efficient and effective, so people with Parkinson's get better symptom control sooner and with fewer visits. The approach uses StimSearch, a semi-automatic algorithm-guided software that analyzes patient assessments and proposes DBS parameter settings, and the study will compare those algorithm suggestions to usual clinician-based programming in a double-blind, randomized way. They are looking for people with confirmed bilateral idiopathic Parkinson's who have significant motor symptoms off medication (UPDRS III ≥ 25), who improved by at least 30% on a pre-operative levodopa challenge, who can give informed consent, and who do not have major psychiatric conditions like substantial depression.
- Who can participate?
- Eligibility criteria vary. Check the full listing on ClinicalTrials.gov for detailed inclusion and exclusion criteria.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 2 years and 1 month.